TABLE 1.
Number of viable M. tuberculosis organisms recovered in spleens and lungs following 6, 8, 10, or 12 weeks of RLZ-INH treatmenta
| Duration (wk) | Mean ± SD log no. of CFU in spleens
|
Mean ± SD log no. of CFU in lungs
|
||||
|---|---|---|---|---|---|---|
| Controlb | Treatment | Treatment + observationc | Control | Treatment | Treatment + observation | |
| 0d | 7.21 ± 0.22 (7/7)e | 5.99 ± 0.21 (7/7) | ||||
| 6 | 1.08 (1/7)f | 3.15 ± 0.56 (7/8) | 0.30 (1/7) | 2.68 ± 0.15 (4/8) | ||
| 8 | 0 (0/8) | 2.93 ± 0.53 (5/8) | 0.70 (1/8) | 2.54 (1/8) | ||
| 10 | 0 (0/8) | 0.22 ± 0.00 (2/8) | 0 (0/8) | 1.45 (1/8) | ||
| 12 | 4.48 ± 0.66 (5/5) | 0 (0/8) | 0 (0/8) | 5.99 ± 0.70 (5/5) | 0 (0/8) | 0 (0/8) |
Groups treated in parallel were maintained to observe regrowth. The mean log number of CFU was calculated for mice in which growth occurred.
One mouse in the 12-week control group died, while the data for the other mice could not be used due to technical error.
Four-month observation phase.
Week 0 represents the beginning of treatment (1 week postinfection).
The values in parentheses represent the number of mice per group (eight per group) in which viable M. tuberculosis was detected/total number of mice in the group.
One mouse died.